AAAAAA

   
Results: 1-20 |
Results: 20

Authors: MEDERSKI WWKR DORSCH D OSSWALD M ANZALI S CHRISTADLER M SCHMITGES CJ SCHELLING P WILM C FLUCK M
Citation: Wwkr. Mederski et al., 3 - ENDOTHELIN ANTAGONISTS - DISCOVERY OF EMD-122946, A HIGHLY POTENTAND ORALLY-ACTIVE ETA SELECTIVE ANTAGONIST, Bioorganic & medicinal chemistry letters, 8(13), 1998, pp. 1771-1776

Authors: ANZALI S MEDERSKI WWKR OSSWALD M DORSCH D
Citation: S. Anzali et al., 1 - ENDOTHELIN ANTAGONISTS - SEARCH FOR SURROGATES OF METHYLENDIOXYPHENYL BY MEANS OF A KOHONEN NEURAL-NETWORK, Bioorganic & medicinal chemistry letters, 8(1), 1998, pp. 11-16

Authors: MEDERSKI WWKR OSSWALD M DORSCH D ANZALI S CHRISTADLER M SCHMITGES CJ WILM C
Citation: Wwkr. Mederski et al., 2 - ENDOTHELIN ANTAGONISTS - EVALUATION OF 2,1,3-BENZOTHIADIAZOLE AS A METHYLENDIOXYPHENYL BIOISOSTER, Bioorganic & medicinal chemistry letters, 8(1), 1998, pp. 17-22

Authors: DORSCH D MEDERSKI WWKR OSSWALD M DEVANT RM SCHMITGES CJ CHRISTADLER M WILM C
Citation: D. Dorsch et al., PYRIDAZINONES WITH A PENDANT ACYLSULFONAMIDE MOIETY AS ENDOTHELIN RECEPTOR ANTAGONISTS, Bioorganic & medicinal chemistry letters, 7(3), 1997, pp. 275-280

Authors: MEDERSKI WWKR OSSWALD M DORSCH D CHRISTADLER M SCHMITGES CJ WILM C
Citation: Wwkr. Mederski et al., ,4-DIARYL-2-OXO-1,2-DIHYRDO-QUINOLINE-3-CARBOXYLIC ACIDS AS ENDOTHELIN RECEPTOR ANTAGONISTS, Bioorganic & medicinal chemistry letters, 7(14), 1997, pp. 1883-1886

Authors: MEDERSKI WWKR DORSCH D OSSWALD M SCHWARTZ H BEIER N CHRISTADLER M MINCK KO SCHELLING P SCHMITGES CJ
Citation: Wwkr. Mederski et al., NOVEL 4,5-DIHYDRO-4-OXO-3H-IMIDAZO[4,5-C]PYRIDINES - POTENT ANGIOTENSIN-II RECEPTOR ANTAGONISTS WITH HIGH-AFFINITY FOR BOTH THE AT(1) AND AT(2) SUBTYPES, European journal of medicinal chemistry, 32(6), 1997, pp. 479-491

Authors: ABDULLA W REHWINKEL R OSSWALD M
Citation: W. Abdulla et al., A NEW APPROACH TO THE TREATMENT OF REFRAC TORY TRIGEMINAL NEURALGIA, Anasthesiologie und Intensivmedizin, 38(6), 1997, pp. 296-303

Authors: SCHROEDER M JASLOWSKI A THOMAS A WARREN T LEWIS S ESSELL J HARMAN G ALLERTON J WILKS S OSSWALD M HALVORSON R
Citation: M. Schroeder et al., BUSULFAN PHARMACOKINETICS IN PATIENTS UNDERGOING BONE-MARROW TRANSPLANT (BMT) - AN ANALYSIS OF THE EFFECTS OF UROSODIOL, Blood, 88(10), 1996, pp. 3762-3762

Authors: RINKEAPPEL J JUNKE N OSSWALD M BRIMACOMBE R
Citation: J. Rinkeappel et al., THE RIBOSOMAL ENVIRONMENT OF TRANSFER-RNA - CROSS-LINKS TO RIBOSOMAL-RNA FROM POSITION-8 AND POSITION-20 1 IN THE CENTRAL FOLD OF TRANSFER-RNA LOCATED AT THE A-SITE, P-SITE, OR E-SITE/, RNA, 1(10), 1995, pp. 1018-1028

Authors: MEDERSKI WWKR DORSCH D OSSWALD M BEIER N LUES I MINCK KO SCHELLING P LADSTETTER BJ
Citation: Wwkr. Mederski et al., 4,5-DIHYDRO-4-OXO-3H-IMIDAZO[4,5-C]PYRIDINES - POTENT ARYLACETIC ACID-DERIVED AT(1) ANTAGONISTS WITH IMPROVED AFFINITY FOR THE AT(2) RECEPTOR, Bioorganic & medicinal chemistry letters, 5(22), 1995, pp. 2665-2670

Authors: DORSCH D MEDERSKI WWKR OSSWALD M BEIER N SCHELLING P
Citation: D. Dorsch et al., URACIL-BASED ANGIOTENSIN-II RECEPTOR ANTAGONISTS, Bioorganic & medicinal chemistry letters, 5(18), 1995, pp. 2071-2076

Authors: MUELLER F DORING T ERDEMIR T GREUER B JUNKE N OSSWALD M RINKEAPPEL J STADE K THAMM S BRIMACOMBE R
Citation: F. Mueller et al., GETTING CLOSER TO AN UNDERSTANDING OF THE 3-DIMENSIONAL STRUCTURE OF RIBOSOMAL-RNA, Biochemistry and cell biology, 73(11-12), 1995, pp. 767-773

Authors: OSSWALD M DORING T BRIMACOMBE R
Citation: M. Osswald et al., THE RIBOSOMAL NEIGHBORHOOD OF THE CENTRAL FOLD OF TRANSFER-RNA - CROSS-LINKS FROM POSITION-47 OF TRANSFER-RNA LOCATED AT THE A-SITE, P-SITEOR E-SITE, Nucleic acids research, 23(22), 1995, pp. 4635-4641

Authors: KOPPE T MEDERSKI WWKR OSSWALD M SCHWARZ M
Citation: T. Koppe et al., ON THE REGIOCHEMISTRY OF THE ALKYLATION OF TERT-BUTYL -BUTYL-1,2-DIHYDRO-2-OXO-3-PYRIDYLMETHYL]CARBAMATE - PRECURSOR OF A SERIES OF POTENT ANGIOTENSIN-II RECEPTOR ANTAGONISTS, Tetrahedron letters, 36(3), 1995, pp. 377-380

Authors: RAYBON K THOMAS A SCHROEDER M LEWIS S CHRISTMAN K WILKS S OSSWALD M ABBOTT K HALVORSON R ESSELL J ALLERTON J
Citation: K. Raybon et al., BONE-MARROW TRANSPLANTATION (BMT) IN MULTIPLE-MYELOMA (MM) WITH BUSULFAN (BU) AND CYCLOPHOSPHAMIDE (CY) - UNACCEPTABLE TOXICITY WITH STANDARD-DOSE IN HEAVILY PRETREATED PATIENTS, Blood, 86(10), 1995, pp. 3833-3833

Authors: SHAUGHNESSY P LEWIS S SCHROEDER M ALLERTON J WILKS S CHRISTMAN K OSSWALD M ABBOTT K HARMON G HALVORSON R SNYDER M CALLANDER N
Citation: P. Shaughnessy et al., BONE-MARROW TRANSPLANTATION FOR PATIENTS WITH SEVERE APLASTIC-ANEMIA USING CYCLOPHOSPHAMIDE AND ANTITHYMOCYTE GLOBULIN (ATG), Blood, 86(10), 1995, pp. 3849-3849

Authors: OSSWALD M DAVIS H ALLERTON J HALVORSEN R
Citation: M. Osswald et al., A STUDY OF MIDCOUNTS AS PREDICTORS OF FINAL YIELD DURING THE HARVEST OF BONE-MARROW FOR TRANSPLANTATION, Blood, 86(10), 1995, pp. 3947-3947

Authors: OSSWALD M MEDERSKI WWKR SCHWARZ M BEIER N LUES I MINCK KO
Citation: M. Osswald et al., 3-SUBSTITUTED 6-BUTYL-1,2-DIHYDROPYRIDIN-2-ONES - A NEW SERIES OF POTENT NONPEPTIDE ANGIOTENSIN-II RECEPTOR ANTAGONISTS, Bioorganic & medicinal chemistry letters, 4(5), 1994, pp. 683-688

Authors: OSSWALD M CALLANDER N JOHNSON M HALVORSON R
Citation: M. Osswald et al., A STUDY OF ULTRAVIOLET-B PHOTOPROPHYLAXIS OF GRAFT-VERSUS-HOST DISEASE IN ALLOGENEIC BONE-MARROW TRANSPLANTATION, Experimental hematology, 22(8), 1994, pp. 695-695

Authors: DORING T MITCHELL P OSSWALD M BOCHKARIOV D BRIMACOMBE R
Citation: T. Doring et al., THE DECODING REGION OF 16S RNA - A CROSS-LINKING STUDY OF THE RIBOSOMAL A-SITE, P-SITE AND E-SITE USING TRANSFER-RNA DERIVATIZED AT POSITION-32 IN THE ANTICODON LOOP, EMBO journal, 13(11), 1994, pp. 2677-2685
Risultati: 1-20 |